Supply

Risk assessing transcribing for administration

28 January 2025Various factors affect the risks associated with using transcribing for medicines administration.

Alternatives to transcribing for medicines administration

28 January 2025Transcribing is not the preferred option for medicines administration and the alternatives should be considered before committing to transcribing.

Managing dosage adjustments for prescribed medicines

23 January 2025Advice on managing medicines that may require dosage adjustments after they have been prescribed.

Registration required

Navigating a potential supply issue

23 January 2025Recommendations for secondary care pharmacy procurement teams to follow before escalating a supply issue or shortage to the SPS Regional Procurement Team.

Understanding why PGDs cannot be used for dose adjustments

23 January 2025This article outlines why PGDs cannot be used to adjust the dosage of a medicine already in an individual's possession.

Supporting system response to the ADHD medicine shortage

1 November 2024Practical advice for the system in response to the NatPSA for Attention Deficit Hyperactivity Disorder (ADHD) medicines.

Administration of contrast agents under a PGD by multiple HCPs

19 August 2024Whether a healthcare professional (HCP) can prepare and/or administer contrast supplied by another HCP under a PGD will depend on a range of factors.

Continuing management of the ADHD medicines shortage

15 July 2024Support for the system in continuing to manage supply disruption of medicines used to treat Attention Deficit Hyperactivity Disorder (ADHD).

Off-label or unlicensed product use under HMR 2012 exemptions

8 April 2024A legal position summary regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the Human Medicines Regulations 2012

Understanding the falsified medicines directive

9 March 2023An overview of the changes to the requirements for medicines ‘safety features’ following the UK’s departure from the EU